NCT01168141View on ClinicalTrials.gov

Window Study of ZD4054 in Metastatic Prostate Cancer

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Prostate CancerMetastasis
Interventions
DRUG

ZD4054

10mg ZD4054 daily in tablet form

Trial Locations (1)

Unknown

The Christie NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

The Christie NHS Foundation Trust

OTHER